Roche expands AI infrastructure with NVIDIA Blackwell GPUs
Roche is adding 2,176 NVIDIA Blackwell GPUs to its AI factory. The company says its hybrid-cloud footprint now exceeds 3,500 GPUs.
Image: Roche
Three misconceptions that limit point-of-care marketing impact
Point-of-care marketing now spans telehealth and retail settings. Three misconceptions about prescribing, cost focus, and measurement transparency can limit impact.
Sanacorp appoints Manuel Kuhn to Board role for Trade
Sanacorp names Manuel Kuhn as Board member for Trade from 1 July 2026. He succeeds Frank Hennings and will oversee sales, purchasing and mea.
apoBank launches new brand campaign “The best choice for healthy finances”
apoBank launched a new brand campaign in March 2026. The claim spotlights the bank’s specialization in healthcare professions across Germany.
Medicos Kosmetik sets up Transformation Office for Dermasence
Medicos Kosmetik has launched a Transformation Office for Dermasence. Christian Mies-Mäkelä has led the new unit since March 2026.
BioNTech co-founders to launch new next-gen mRNA company
BioNTech says co-founders Ugur Sahin and Özlem Türeci plan a new independent next-gen mRNA company. Management transition is expected by end of 2026.
BC Partners and Bpifrance complete acquisition of Biogaran
BC Partners and Bpifrance have completed the acquisition of Biogaran from Servier. Erick Roche is set to become CEO by the end of March 2026.
Hikma reports revenue and core profit growth, launches buyback and reshuffles leadership
Hikma posted 2025 revenue and core profit growth, lifted its dividend and announced a US$250m share buyback plus immediate leadership changes.
AI Pharmaday 2026 in Munich spotlights real-world execution
AI Pharmaday is scheduled for 16 April 2026 in Munich. The agenda focuses on practical AI use cases across pharma and pharmacies, from idea to delivery.
Esperion to acquire Corstasis to add Enbumyst to its CV portfolio
Esperion has signed a definitive deal to acquire Corstasis. The transaction adds Enbumyst, an FDA-approved bumetanide nasal spray for edema.